Mukka Proteins Limited — Important, 14-11-2024: Financial Result Updates

Mukka Proteins Limited reported its financial results for the quarter and half-year ending September 30, 2024.

Consolidated revenue from operations for the quarter stood at ₹1,491.94 crore, representing a year-over-year decline of approximately 54.98%. For the half-year, total revenue reached ₹3,216.93 crore, indicating a drop of about 58.21% from the previous year. The decline in revenue is attributed to lower demand and inventory adjustments, impacting overall sales performance.

Net profit for the quarter was ₹14.71 crore, down from ₹286.76 crore a year ago, resulting in an earnings per share (EPS) of ₹0.07. The decrease in profitability reflects higher operational costs, particularly in material consumption and financing expenses. Profit after tax for the half-year reached ₹72.98 crore, compared to ₹329.81 crore in the previous half-year.

Operational costs increased significantly, with a cost of materials consumed at ₹1,292.28 crore for the quarter, underscoring challenges in cost management and supply chain issues.

The consolidated balance sheet showed total assets of ₹9,044.16 crore, with total equity at ₹4,138.36 crore, strengthening the company’s financial position despite recent operational challenges.

Future strategic focus should include enhancing operational efficiencies and exploring new market opportunities. Overall, investor sentiment may lean towards a cautious stance given the current revenue challenges. A hold insight is advised, considering potential recovery strategies and ongoing market dynamics.